Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente NEURO-ONCOLOGY

Tipo Año Título Fuente
Artículo2023Non-metabolic functions of phosphofructokinase-1 orchestrate tumor cellular invasion and genome maintenance under bevacizumab therapyNEURO-ONCOLOGY
Artículo2022Selective blood-brain barrier permeabilisation of brain metastases by a type-1 receptor selective tumour necrosis factor mutein.NEURO-ONCOLOGY
Resumen congreso2022Tumour-infiltrated cortex participates in large-scale cognitive circuitsNEURO-ONCOLOGY
Corrección2021Erratum: Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo (Neuro-Oncology DOI: 10.1093/neuonc/noz243)NEURO-ONCOLOGY
Resumen congreso2021Longitudinal connectome analyses following low-grade glioma neurosurgery: implications for cognitive rehabilitationNEURO-ONCOLOGY
Resumen congreso2021Proposed origins and pathways of diffuse gliomas revealed by lesion covariance networksNEURO-ONCOLOGY
Artículo2020Connexin43 peptide, TAT-Cx43(266-283), selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivoNEURO-ONCOLOGY
Resumen congreso2020Genetic, cellular, and connectomic characterization of the adult human brain regions commonly plagued by gliomaNEURO-ONCOLOGY
Artículo2020JAM-A functions as a female microglial tumor suppressor in glioblastomaNEURO-ONCOLOGY
Artículo2020VCAM-1 targeted alpha-particle therapy for early brain metastasesNEURO-ONCOLOGY
Resumen congreso2019Glioblastoma and Alzheimer pathology: lessons from a single case with practical implications and need for further researchNEURO-ONCOLOGY
Ponencia2018Anti-vcam-1 targeted mri allows earlier detection of brain metastases in a xenograft melanoma mouse modelNEURO-ONCOLOGY
Resumen congreso2018Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors - Is It worth it?NEURO-ONCOLOGY
Resumen congreso2018Identification of novel radiosensitizers in glioblastoma cancer stem-like cellsNEURO-ONCOLOGY
Resumen congreso2018Salvage frameless stereotactic radiosurgery as first treatment option for recurrent brain metastases. May durable intracranial control be achieved?NEURO-ONCOLOGY
Resumen congreso2018Spt6 regulates transcription by stabilizing RNA POL II and so drives glioblastoma cancer stem-like cell maintenanceNEURO-ONCOLOGY
Resumen congreso2018The role of RAD52 in genomic instability and therapeutic resistance of malignant gliomasNEURO-ONCOLOGY
Ponencia2017A brain metastasis therapy tweak, for the better? concomitant stereotactic radiotherapy & molecular-targeted therapyNEURO-ONCOLOGY
Ponencia2017The ambiguity of brain metastasis response to radiotherapy driven by cellular adhesion moleculesNEURO-ONCOLOGY
Artículo2016Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51NEURO-ONCOLOGY
Resumen congreso2014Er-stress inducing drugs sensitizes GBM to temozolomide through downregulation of MGMT and induction of regulated necrosisNEURO-ONCOLOGY
Artículo2014Functional role of endothelial adhesion molecules in the early stages of brain metastasisNEURO-ONCOLOGY
Ponencia2013Development of a DIPG orthotopic model in nude mice using an implantable guided- screw systemNEURO-ONCOLOGY
Ponencia2012Immunotherapy with tumor lysate-pulsed dendritic cells for newly-diagnosed glioblastoma following fluorescence-guided resectionNEURO-ONCOLOGY
Ponencia2008Long-term survival of a pediatric patient with glioblastoma multiforme (GBM) following multiple treatments with carmustine (BCNU) wafers and temozolomide (TMZ)NEURO-ONCOLOGY
Resumen congreso2008Surgery guided by 5ala fluorescence is a safe and efficient method with the potential to greatly increase the rate of gross total resection in glioblastomaNEURO-ONCOLOGY